Related Experiment Video

Updated: Jun 9, 2026

Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia
08:48

Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia

Published on: May 6, 2016

Pilot trial of memantine in primary progressive aphasia

Nancy A Johnson, Alfred Rademaker, Sandra Weintraub

    Alzheimer Disease and Associated Disorders
    |August 28, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
    06:22

    A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid

    Published on: September 3, 2021

    Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia
    10:15

    Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

    Published on: July 2, 2013

    Related Experiment Videos

    Last Updated: Jun 9, 2026

    Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia
    08:48

    Neuronavigation-guided Repetitive Transcranial Magnetic Stimulation for Aphasia

    Published on: May 6, 2016

    A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
    06:22

    A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid

    Published on: September 3, 2021

    Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia
    10:15

    Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

    Published on: July 2, 2013

    Related Concept Videos

    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

    Articles linked to this work by shared authors, journal, and citation graph.

    Person-centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge-2 randomized clinical trial.

    Alzheimer's & dementia (New York, N. Y.)·2026

    Clinical Manifestations.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Biomarkers.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Basic Science and Pathogenesis.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Dementia Care Research and Psychosocial Factors.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Dementia Care Research and Psychosocial Factors.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

    Age-Dependent and APOE-Modified Associations Between Vascular Risk Factor Patterns and Cognitive Function: A Latent Class Analysis of 44,879 NACC Participants.

    Alzheimer disease and associated disorders·2026

    Co-Design and Development of Digital Health Solution for Informal Alzheimer's Caregivers.

    Alzheimer disease and associated disorders·2026

    Hypertension and 10-Year Dementia Risk Among Older Asian American and Non-Latino White Adults in Northern California.

    Alzheimer disease and associated disorders·2026

    Factors for Avoiding Counseling Despite Experiencing Cognitive Impairment in South Korea: An Age-Stratified Analysis of the Korea Community Health Survey.

    Alzheimer disease and associated disorders·2026

    Projected Global and SDI-Region Care Costs for Alzheimer Disease and Associated Dementias, 2023 to 2050: A Stratified Analysis Based on Global Burden of Disease (GBD) Data.

    Alzheimer disease and associated disorders·2026

    Discordance Between Cognitive Impairment Status and Claims-Based ADRD Diagnosis: Temporal Patterns and Racial Differences in the REGARDS Cohort, 2006 to 2021.

    Alzheimer disease and associated disorders·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us